drugset
drugset / Trial / NCT04804904

A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

NCT04804904 ↗

Phase 1 Completed 16 enrolled Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

Evaluate the effect of food on the pharmacokinetics of TQB3101 in healthy subjects.

Timeline

Start
2021-05-20
Primary completion
2021-06-15
Completion
2021-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Unecritinib Small molecule — Oral

Indications

No indication recorded.